Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

JANX Janux Therapeutics Inc

39,50

-1,81 (-4,38%)

Vor Marktöffnung

Zuletzt aktualisiert: 13:22:26

Verzögert um 15 Minuten

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

Janux Therapeutics (NASDAQ:JANX)
Historical Stock Chart
Von Jan 2025 bis Feb 2025

Click Here for more Janux Therapeutics Charts.

Janux Therapeutics (NASDAQ:JANX)
Historical Stock Chart
Von Feb 2024 bis Feb 2025

Click Here for more Janux Therapeutics Charts.

News Janux Therapeutics Inc

Form 144 - Report of proposed sale of securities
Montag 3 Februar 2025 (2 Tage vor) • Edgar (US Regulatory)

Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer
Freitag 24 Januar 2025 (2 Wochen vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 9 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Dienstag 7 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
Samstag 4 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Samstag 4 Januar 2025 (1 Monat vor) • Edgar (US Regulatory)

Weitere Janux Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen